The timely and effective delivery of approved vaccines to the population of India will require a comprehensive approach for vaccine manufacturers and distribution networks that must operate under the guidelines of the Indian Government and collaborate with distributors and hospitals under rigorous conditions of the cold chain, safety and regulatory compliance. BIORx Venture shares an incisive, strategy-first look at the challenges of vaccine procurement, storage and distribution that the entire community must face head-on in 2021.
Future Healthcare: Focused on Scope of Clinical Informa ...2021-07-21
WHEN IT COMES TO PATIENT CENTRICITY, IT PAYS TO GO TECH ...2021-07-19
Comprehensive Genomic Profiling (CGP): Modern standard ...2021-06-14
BRINGING THE BLOOD BANK INTO EVERYONEÃ¢â‚¬â„¢ ...2021-06-14
Our Pandemic Response: Wavering between Complacency and ...2021-06-10 View All